Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jan 14, 2026

Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility

Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility

Published on: August 11, 2023

Cold Chain Delivery in Cell Therapies.

Peter Kilbride¹

¹Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK. peter.kilbride@wrh.ox.ac.uk.

Advances in Experimental Medicine and Biology

|October 24, 2025

Summary

Ultra-low cryogenic shipment is vital for cell therapies, requiring specialized logistics. This guide details cold chain best practices for high-value, temperature-sensitive cell and gene therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trehalose in cryopreservation. Applications, mechanisms and intracellular delivery opportunities.

RSC medicinal chemistry·2024

Same author

Acidic polymers reversibly deactivate phages due to pH changes.

RSC applied polymers·2024

Same author

Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing.

PloS one·2024

Same author

Screening of Hydrophilic Polymers Reveals Broad Activity in Protecting Phages during Cryopreservation.

Biomacromolecules·2023

Same author

Engineered Test Tissues: A Model for Quantifying the Effects of Cryopreservation Parameters.

ACS biomaterials science & engineering·2023

Same author

Cryopreservation of mouse thymus depletes thymocytes but supports immune reconstitution on transplantation.

European journal of immunology·2023

Area of Science:

Biotechnology
Logistics
Cellular Therapy

Background:

Cell therapies require specialized cold chain logistics for patient access.
Cryopreserved cell therapy shipments demand ultra-low temperatures, unlike conventional cold chain.
These high-value shipments necessitate strict chain of custody and traceability.

Purpose of the Study:

To provide a guide for developing and managing cell therapy cold chain logistics.
To analyze the pros and cons of various temperature shipments, from ambient to LN2.
To outline key considerations for custom shipping system development.

Main Methods:

Review of different temperature shipment options (unfrozen to LN2).
Analysis of typical cryogenic shipping processes and critical control points.

Keywords:

Cell therapies Chain of custody Clinical delivery Cold-chain Cryopreservation Dry ice Dry shipper Logistics Regenerative medicine Shipping

More Related Videos

Freezing, Thawing, and Packaging Cells for Transport

Freezing, Thawing, and Packaging Cells for Transport

Published on: July 2, 2008

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Related Experiment Videos

Last Updated: Jan 14, 2026

Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility

Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility

Published on: August 11, 2023

Freezing, Thawing, and Packaging Cells for Transport

Freezing, Thawing, and Packaging Cells for Transport

Published on: July 2, 2008

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Consideration of practical aspects for developing custom cold chain solutions.

Main Results:

Identification of unique challenges in cryopreserved cell therapy shipments.
Evaluation of temperature ranges and their impact on shipment integrity.
Discussion of essential steps beyond standard logistics for cell therapies.

Conclusions:

Optimized cold chain management is crucial for the success of cell therapies.
Understanding temperature requirements and chain of custody is paramount.
Future logistics must adapt to the increasing complexity and prevalence of cell-based treatments.